Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jodi F, Leverone"'
Autor:
Cynthia A Lemere, Edward T Spooner, John LaFrancois, Brian Malester, Chica Mori, Jodi F Leverone, Yasuji Matsuoka, Jennie W Taylor, Ronald B DeMattos, David M Holtzman, John D Clements, Dennis J Selkoe, Karen E Duff
Publikováno v:
Neurobiology of Disease, Vol 14, Iss 1, Pp 10-18 (2003)
Immunization with amyloid-β (Aβ) peptide in mouse models of Alzheimer’s disease has been reported to decrease cerebral Aβ levels and improve behavioral deficits. Several mechanisms have been proposed, including antibody-induced phagocytosis of A
Externí odkaz:
https://doaj.org/article/4f47f1c3bb8b443086efd9bb58489f0a
Autor:
John LaFrancois, Yasuji Matsuoka, Jodi F. Leverone, Karen Duff, Chica Mori, John D. Clements, Brian Malester, Cynthia A. Lemere, Edward T. Spooner, David M. Holtzman, Dennis J. Selkoe, Jennie W. Taylor, Ronald Demattos
Publikováno v:
Neurobiology of Disease, Vol 14, Iss 1, Pp 10-18 (2003)
Immunization with amyloid-beta (Abeta) peptide in mouse models of Alzheimer's disease has been reported to decrease cerebral Abeta levels and improve behavioral deficits. Several mechanisms have been proposed, including antibody-induced phagocytosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93761453639de3c34940f318b40b32f8
https://doi.org/10.1016/s0969-9961(03)00044-5
https://doi.org/10.1016/s0969-9961(03)00044-5
Publikováno v:
Vaccine. 21:2197-2206
Immunizing mouse models of Alzheimer's disease (AD) against beta-amyloid (Abeta) leads to a decrease in cerebral Abeta burden as well as an improvement in behavioral deficits. Circulating Abeta-antibodies may be responsible for interfering with Abeta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::495243142c91e7d5b43c32c6c30dcdb2
https://doi.org/10.1016/s0264-410x(02)00754-5
https://doi.org/10.1016/s0264-410x(02)00754-5
Autor:
Edward T. Spooner, Timothy J. Seabrook, Jeanne K. Bloom, Jodi F. Leverone, Chica Mori, Melitza Iglesias, Cynthia A. Lemere
Publikováno v:
Neurochemical Research. 28:1017-1027
Alzheimer's disease is the most prevalent form of dementia worldwide. Therapies are desperately needed to prevent and cure the disease. Mouse models of amyloid-β deposition [APP and PSAPP transgenic (tg) mice] have been useful in determining the rol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ef452f589dfa44f7521e07e62cd5d78
https://doi.org/10.1023/a:1023203122036
https://doi.org/10.1023/a:1023203122036
Autor:
Dora Louard, Dennis J. Selkoe, Frank R. Ervin, Amy Beierschmitt, Timothy J. Seabrook, Melitza Iglesias, Roberta M. Palmour, Edward T. Spooner, Jeanne K. Bloom, Diana Li, Jessica B. Zheng, Jodi F. Leverone, Cynthia A. Lemere
Publikováno v:
The American journal of pathology. 165(1)
Amyloid beta (Abeta) protein immunotherapy lowers cerebral Abeta and improves cognition in mouse models of Alzheimer's disease (AD). Here we show that Caribbean vervet monkeys (Chlorocebus aethiops, SK) develop cerebral Abeta plaques with aging and t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65576d3bb3aefa8954be076b2840799f
https://pubmed.ncbi.nlm.nih.gov/15215183
https://pubmed.ncbi.nlm.nih.gov/15215183
Autor:
Cynthia A, Lemere, Edward T, Spooner, Jodi F, Leverone, Chica, Mori, Melitza, Iglesias, Jeanne K, Bloom, Timothy J, Seabrook
Publikováno v:
Neurochemical research. 28(7)
Alzheimer's disease is the most prevalent form of dementia worldwide. Therapies are desperately needed to prevent and cure the disease. Mouse models of amyloid-beta deposition [APP and PSAPP transgenic (tg) mice] have been useful in determining the r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fe8babe9bca632538046c914732de593
https://pubmed.ncbi.nlm.nih.gov/12737526
https://pubmed.ncbi.nlm.nih.gov/12737526
Publikováno v:
Neurobiology of aging. 23(6)
Alzheimer's disease (AD) is the most common form of dementia worldwide, yet there is currently no effective treatment or cure. Extracellular deposition of amyloid-beta protein (Abeta) in brain is a key neuropathological characteristic of AD. In 1999,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f9917b71f5b7d993898d016977085c9
https://pubmed.ncbi.nlm.nih.gov/12470794
https://pubmed.ncbi.nlm.nih.gov/12470794